H-Phg-OtBu

H-Phg-OtBu is an amino acid derivative corresponding to a phenylglycine (Phg) residue bearing a free amino group and a tert-butyl ester (OtBu) at the carboxyl terminus. The molecule contains a benzylic chiral center typical of phenylglycine stereochemistry, a primary amine suitable for acylation, and an ester-protected carboxyl group that can be selectively activated for peptide coupling or converted to carboxylic acid derivatives under controlled conditions. The tert-butyl ester provides acid-labile protection behavior that supports orthogonal deprotection strategies alongside other side-chain or backbone protecting groups. The aromatic phenyl substituent and the benzylic linkage influence conformational preferences and can modulate reactivity during amide bond formation, making the compound a practical chiral intermediate for peptide building block preparation and downstream derivatization.

1. Peptide Synthesis

H-Phg-OtBu supports peptide coupling chemistry through its free amino functionality for N-acylation and its tert-butyl ester for protected C-terminal handling during solid-phase or solution-phase assembly. The chiral phenylglycine center enables stereodefined incorporation into peptide sequences, while the OtBu ester can be maintained during coupling steps and then converted to a carboxylate for subsequent elongation or terminal functionalization. The aromatic side chain participates in hydrophobic and stacking interactions that are relevant for peptide folding studies and peptidomimetic scaffold design. The compound can be employed as a protected amino acid intermediate for constructing amide linkages with standard coupling reagents and for generating sequence-defined chiral analogs for SAR-oriented peptide research.

2. Protected Amino Acid Chemistry

H-Phg-OtBu functions as a chiral amino acid ester intermediate where the tert-butyl ester serves as a removable carboxyl protecting group compatible with orthogonal protection schemes. The free amine enables controlled formation of N-protected derivatives (for example, via acylation to introduce peptide-grade N-protecting groups), while the OtBu ester can be hydrolyzed or deprotected to furnish carboxylic acids for further functional group transformations. The benzylic stereocenter provides a defined stereochemical handle for stereoselective synthesis routes and for maintaining configuration during downstream derivatization. The resulting carboxylate or activated acid derivatives can feed into peptide building block preparation, chiral auxiliary-free synthesis, and fine chemical manufacturing workflows that require protected amino acid intermediates.

3. Peptidomimetics And SAR Studies

H-Phg-OtBu is suitable for constructing peptidomimetic libraries and structure-activity relationship (SAR) studies where phenylglycine incorporation tunes backbone geometry and aromatic side-chain presentation. The amino and ester groups enable stepwise conversion into amide-linked analogs, while stereochemical control at the benzylic position supports generation of diastereomerically defined series for comparative binding or conformational analysis. The aromatic phenyl substituent can be leveraged to create hydrophobic pharmacophore elements within constrained peptide-like frameworks. The compound can be applied to generate chiral intermediate sets for medicinal chemistry campaigns focused on backbone modification strategies and amino acid derivatization pathways.

4. Chiral Building Block Development

H-Phg-OtBu serves as a chiral amino acid intermediate for stereocontrolled synthesis of benzylic amino acid derivatives and related chiral fragments used in synthetic organic chemistry. The presence of a stereogenic center adjacent to the amine and aromatic ring supports downstream transformations such as conversion to activated carboxylic acid forms, formation of N-acyl derivatives, and preparation of coupling-ready building blocks. The OtBu ester provides a protected handle that can be carried through selective functional group manipulations before deprotection to regenerate a reactive acid functionality. The compound can be utilized to supply enantiomerically defined intermediates for chiral scaffold assembly, including peptide analog construction and chiral derivatization routes for analytical or synthetic method development.

5. Pharmaceutical Intermediate Preparation

H-Phg-OtBu can be used in pharmaceutical intermediate preparation where protected amino acid building blocks are required for controlled amide formation and subsequent deprotection to yield reactive carboxylic acid or activated derivatives. The OtBu ester offers process-relevant protection of the carboxyl group during coupling and intermediate handling, while the free amine supports conversion to N-protected forms that align with peptide-like synthetic sequences. The phenylglycine motif introduces an aromatic chiral element that is commonly integrated into medicinal chemistry intermediates for generating diverse analogs. The compound can be employed as a manufacturing route intermediate for producing chiral amino acid derivatives that feed into downstream synthesis of peptide-based candidates, peptidomimetics, and other amide-rich structures.

1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

2. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy